YMC Completes Phase 1 of Growth Plan in America
YMC America has completed the successful co-location and expansion of its US business operations at its growing campus in Devens, MA. The purpose of the move was to consolidate operations in a single facilities center, while also adding much-needed expansion of resources, space, and laboratories. Read more at link.
Previous Article
YMC 5 Year Vision Related Posts
June 2, 2026
Chromatography of Biotherapeuticals – Analyzing and Purifying Peptides and Oligonucleotides
This webinar will highlight how advanced ultra-high-performance liquid chromatography (UHPLC) strategies, carefully selected stationary phases, and bioinert hardware can significantly improve the analysis and purification of peptides and oligonucleotides.
May 21, 2026
Breaking Down mRNA Capping Efficiency with High-Resolution IP-RP LC
Evaluating 5' capping efficiency is a critical quality attribute in therapeutic mRNA manufacturing, directly impacting translation efficiency and transcript stability. However, separating structurally similar capped, partially capped, and uncapped species differing by just a single nucleotide remains a significant chromatographic challenge.
May 7, 2026
Revolutionizing CRISPR Applications: High-Resolution sgRNA Analysis
Ensuring the quality of single guide RNA (sgRNA) is a major hurdle in CRISPR-Cas genome editing. Because these molecules are large (~100mer) and prone to complex secondary structures, separating them from nearly identical impurities requires precision. Our latest application note
